1. Home
  2. EDAP vs FVCB Comparison

EDAP vs FVCB Comparison

Compare EDAP & FVCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDAP
  • FVCB
  • Stock Information
  • Founded
  • EDAP 1979
  • FVCB 2007
  • Country
  • EDAP France
  • FVCB United States
  • Employees
  • EDAP N/A
  • FVCB N/A
  • Industry
  • EDAP Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • FVCB Major Banks
  • Sector
  • EDAP Health Care
  • FVCB Finance
  • Exchange
  • EDAP Nasdaq
  • FVCB Nasdaq
  • Market Cap
  • EDAP 113.2M
  • FVCB N/A
  • IPO Year
  • EDAP 1997
  • FVCB N/A
  • Fundamental
  • Price
  • EDAP $2.65
  • FVCB $13.57
  • Analyst Decision
  • EDAP Strong Buy
  • FVCB
  • Analyst Count
  • EDAP 2
  • FVCB 0
  • Target Price
  • EDAP $14.00
  • FVCB N/A
  • AVG Volume (30 Days)
  • EDAP 60.8K
  • FVCB 23.1K
  • Earning Date
  • EDAP 11-07-2024
  • FVCB 10-29-2024
  • Dividend Yield
  • EDAP N/A
  • FVCB N/A
  • EPS Growth
  • EDAP N/A
  • FVCB N/A
  • EPS
  • EDAP N/A
  • FVCB 0.24
  • Revenue
  • EDAP $66,481,303.00
  • FVCB $44,610,000.00
  • Revenue This Year
  • EDAP $9.53
  • FVCB N/A
  • Revenue Next Year
  • EDAP $15.87
  • FVCB $14.51
  • P/E Ratio
  • EDAP N/A
  • FVCB $56.40
  • Revenue Growth
  • EDAP 8.79
  • FVCB N/A
  • 52 Week Low
  • EDAP $2.45
  • FVCB $9.78
  • 52 Week High
  • EDAP $8.50
  • FVCB $15.39
  • Technical
  • Relative Strength Index (RSI)
  • EDAP 36.17
  • FVCB 64.86
  • Support Level
  • EDAP $2.56
  • FVCB $12.39
  • Resistance Level
  • EDAP $2.82
  • FVCB $13.94
  • Average True Range (ATR)
  • EDAP 0.17
  • FVCB 0.36
  • MACD
  • EDAP 0.04
  • FVCB 0.06
  • Stochastic Oscillator
  • EDAP 37.04
  • FVCB 78.21

About EDAP EDAP TMS S.A.

Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its global activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.

Share on Social Networks: